Cdt Equity logo

Cdt Equity(NASDAQ) CDTTW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-97%
5 YearN/A
1 Year-69%
1 Month-43%
$0.01
+107.41%
+0.00Today
Cdt Equity last closing stock price
MetricPriceDate
Last closeUSD 0.012026-10-13
Cdt Equity stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-52.14%USD 0.012026-10-06
1 month-43.43%USD 0.012026-09-11
3 month-49.1%USD 0.012026-07-13
Year to date+1.82%USD 0.012025-12-31
1 year-68.89%USD 0.022025-10-13
3 year-87.56%USD 0.052023-10-11
Since inception-96.71%USD 0.172022-03-31

Cdt Equity Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.45B

Net Income (TTM)

$91.12M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.01

Volume

28,551

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

N/A

CDTTW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cdt Equity

CDT Equity Inc. is a biotechnology company focused on advancing the development and market introduction of clinical assets. Established in October 2021, the company operates from Naples, Florida, and is committed to innovative healthcare solutions.

Products and Services
  • Development of clinical assets in biotechnology
  • Research and development in healthcare solutions
  • Market introduction of innovative medical technologies
Growth Outlook
  • Revenue increased to $750 million in Q2 2026, up from $696 million in Q1 2026
  • Gross profit margin improved to 40.1% in Q2 2026
  • Net income reached $68.5 million in Q2 2026, indicating strong profitability
Financial Highlights
  • Trailing twelve months (TTM) revenue of $1.446 billion
  • Operating income margin of 15.6% in Q2 2026
  • Cash and cash equivalents of $348.7 million as of June 30, 2026
CDT Equity Inc. has shown significant growth in its financial performance, particularly in the most recent quarter. The increase in revenue and improvement in gross profit margin reflect the company's effective operational strategies and market positioning. The strong net income indicates a robust profitability trend, which may attract potential investors looking for opportunities in the biotechnology sector. With a solid cash position, the company is well-equipped to fund ongoing research and development initiatives, further enhancing its growth potential in the healthcare market.
AI Generated • Oct 13, 2026

Industry

Life Sciences Tools and Services

Headquarters

Naples, FL 34103, US

CDTTW Financials

Key Financial Metrics (TTM)

Gross Margin

38.65%

Operating Margin

11.55%

Net Income Margin

6.30%

Return on Equity

9.26%

Return on Capital

-1.44%

Return on Assets

2.60%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

6.47%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

28.55K

Avg. Volume

20.02K

Financials (TTM)

Gross Profit

$559.12M

Operating Income

$167.14M

EBITDA

$211.29M

Operating Cash Flow

$124.45M

Capital Expenditure

-$125.74M

Free Cash Flow

-$1.29M

Cash & ST Invst.

$348.66M

Total Debt

$1.32B

Cdt Equity Performance Analysis

Cdt Equity sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-28N/A
Q42025-12-31N/A
Q12026-03-29N/A
Q22026-06-307.7%
Cdt Equity sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-2869.9%
Q42025-12-3129.7%
Q12026-03-2997.6%
Q22026-06-3084.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$750.16M

N/A

Gross Profit

$301.03M

N/A

Gross Margin

40.13%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

4

N/A

Net Income

$68.54M

+1237.0%

EBITDA

$127.67M

+2582.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$348.66M

+10363.8%

Total Debt

$1.32B

+63754.2%

Accounts Receivable

$534.16M

+217924.1%

Inventory

$420.59M

N/A

Long Term Debt

$1.32B

+2867787.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

2.60%

N/A

Return on Invested Capital

5.86%

N/A

Free Cash Flow

$2.08M

+180.6%

Operating Cash Flow

$42.74M

+1756.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DRMADermata Therapeutics, Inc.
$0.86-3.34%
AKTXAkari Therapeutics, Plc
$7.90-7.49%
XAGELongevity Health Holdings Inc.
$0.11+0.90%
PPBTPurple Biotech Ltd.
$1.36-1.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
CIFRCipher Digital
$11.34-12.77%
BMBLBumble
$5.95+56.58%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
INTCIntel
$102.81+1.44%

Questions About CDTTW

What is the current price of Cdt Equity?

Cdt Equity is trading at $0.01 per share.

What is the 52-week range for Cdt Equity?

Over the past 52 weeks, Cdt Equity has traded between $0.00 and $0.02.

How much debt does Cdt Equity have?

Cdt Equity total debt is unavailable.

How much cash does Cdt Equity have on hand?

Cdt Equity does not have cash on hand data available.

What is Cdt Equity’s dividend yield?

Cdt Equity does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.